Apellis Pharma Inc - APLS - stock price prediction, stock price target, analyst ratings from 21 analysts

Apellis Pharma Inc has a share price target of US$ 34, revenue growth forecast of 28.6%, and profit growth estimate of 117.5% for FY25, based on top 21 analyst calls.